Search research articles
Contact Us
Filters
Showing results (141-150 of 158) with videos related to
Page
of 16
Sort By:
Journal of Medicinal Chemistry
|
December 8, 2020
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors
Samantha Caputo, Simona Di Martino, Vincenzo Cilibrasi, et al.
Angewandte Chemie (International Ed. in English)
|
December 16, 2014
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Federica Prati, Angela De Simone, Paola Bisignano, et al.
Acta Neuropathologica
|
March 14, 2016
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet
Anna Rocchi, Carmelo Milioto, Sara Parodi, et al.
Journal of Medicinal Chemistry
|
March 17, 2020
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors
Simona Di Martino, Piero Tardia, Vincenzo Cilibrasi, et al.
Scientific Reports
|
July 15, 2017
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo, Enrico Amico, Abdul Basit, et al.
Scientific Reports
|
May 26, 2018
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo, Enrico Amico, Abdul Basit, et al.
Brain : a Journal of Neurology
|
July 29, 2025
Connectomic and behavioural alterations in creatine transporter deficiency are partially normalized by gene therapy
Caterina Montani, Ludovica Iovino, Federica Di Vetta, et al.
Angewandte Chemie (International Ed. in English)
|
July 13, 2016
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
Marco Migliore, Silvia Pontis, Angel Luis Fuentes de Arriba, et al.
Iscience
|
September 15, 2025
CDC42-effector interaction inhibitors alter patterns of vessel arborization in skin and tumors <i>in vivo</i>
Linh M Vuong, Stephanie Hachey, Jessica Shiu, et al.
Molecular Therapy. Nucleic Acids
|
December 30, 2025
Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets
Silvia Rancati, Rui C Pereira, Michele Schlich, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 158) with videos related to
Sort By:
Page
of 16
Journal of Medicinal Chemistry
|
December 8, 2020
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors
Samantha Caputo, Simona Di Martino, Vincenzo Cilibrasi, et al.
Angewandte Chemie (International Ed. in English)
|
December 16, 2014
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Federica Prati, Angela De Simone, Paola Bisignano, et al.
Acta Neuropathologica
|
March 14, 2016
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet
Anna Rocchi, Carmelo Milioto, Sara Parodi, et al.
Journal of Medicinal Chemistry
|
March 17, 2020
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors
Simona Di Martino, Piero Tardia, Vincenzo Cilibrasi, et al.
Scientific Reports
|
July 15, 2017
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo, Enrico Amico, Abdul Basit, et al.
Scientific Reports
|
May 26, 2018
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo, Enrico Amico, Abdul Basit, et al.
Brain : a Journal of Neurology
|
July 29, 2025
Connectomic and behavioural alterations in creatine transporter deficiency are partially normalized by gene therapy
Caterina Montani, Ludovica Iovino, Federica Di Vetta, et al.
Angewandte Chemie (International Ed. in English)
|
July 13, 2016
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
Marco Migliore, Silvia Pontis, Angel Luis Fuentes de Arriba, et al.
Iscience
|
September 15, 2025
CDC42-effector interaction inhibitors alter patterns of vessel arborization in skin and tumors <i>in vivo</i>
Linh M Vuong, Stephanie Hachey, Jessica Shiu, et al.
Molecular Therapy. Nucleic Acids
|
December 30, 2025
Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets
Silvia Rancati, Rui C Pereira, Michele Schlich, et al.
Page
of 16